Hepatotoxicity of antiretroviral drugs in HIV seropositive Nigerian patients

Australian Journal of Basic and Applied Sciences

Volumn 4, Issue 9, 2010, Pages 4275-4278

  Emejulu, A A ^a   Ujowundu, C O ^a   Igwe, C U ^a   Ouwuliri, V A ^a  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Antiretroviral drugs; Hepatotoxicity; Liver function test; Nigeria

Indexed keywords

EID: 78649368652     PISSN: 19918178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ashford, L.S., 2006. How HIV and AIDS affect populations. Population Reference Bureau, Washington DC www.prb.org.
2. Balistreri, W.F. and L.M. Shaw, 1987. Liver function In: Tietz, N.W. ed. Fundamentals of Clinical Chemistry. W.B. Saunders Company, Philadelphia, pp: 729-760.
3. Ezioba, E.F., 2006. www.northsouth.ethz.ch/../NIDECO_Potrait_Anual_Report_2005.
4. Harris, A.D., 2001. AIDS Review. African Health, 23(2): 22-23.
5. Harris, A.D., 2002. Antiretroviral Therapy in sub-saharan Africa. African Health, 24(2): 18-21.
6. Julio, S.G., H.C. Montaner, H. Marianne, S.R. Hogg and M.V. O'Shaughnessy, 2004. Nucleoside-Related mitochondrial Toxicity Among HIV-Infected Patients Receiving Antiretroviral Therapy: Insights from the Evaluation of Venous Lactic Acid and Peripheral Blood Mitochondrial DNA. Clinical Infectious Diseases, 38: 573-579.
7. Lamptey, P.R., J.L. Johnson and M. Khan, 2006. The Global Challenge of HIV and AIDS. Population Bulletin, 61(1): 8-9.
8. Mandelbrot, L., M.A. Landreau and E. Blanche, 2001. Agence Nationale de Research's sur le JAMA, 285(16): 2083-2093.
9. Maurizo, B., 2004. Liver injury during HAART: The Effect of HCV Co-infections. Clinical infectious Disease, 38: 5104-5108.
10. Neil, K., 2004. HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms. Clinical Infectious Disease, 38(5): 605-640.
11. NIAID, 1999. HIV/AIDS update. National Institute of Allergy and Infectious Diseases, National Institute for Health, 4: 5.
12. CaCoub, P., P. Stanislas, C. Perronne and the ANRS HCO2-Ribavic study Team, 2004. Management of the Co-infected Patient with Human Immunodeficiency Syndrome on Course of Hepatitis C Virus Infection: A Meta Analysis. I n f e c t i o u s Disease in Clinical Practice 15(1): 38-48. www.journals.uchicago.edu/doi/pdf/10.1086/321909.
13. Sulkowski, M.S., S.H. Mehta R.E. Chaisson, D.L. Thomas and R.D. Moore, 2004. Hepatotoxicity associated with protease inhibitor based antiretroviral regimens with or without concurrent ritonavir. AIDS (London), 18(17): 2277-84.
14. TDR, 2002. Workbook for Investigators. UNDP/World Bank/WHO special Programme for Research and Training in Tropical Diseases. TDR/PRD/GLP.
15. UNAIDS, 2006. Report on the Global AIDS Epidemic UNAIDS, Geneva.
16. UNAIDS/WHO, 2002. HIV/AIDS in Sub-Saharan Africa. Weekly Epidemiol. Rec., 85: 150-156.
17. WHO, 1992. Global Programme on AIDS-Recommendations for selection and use of HIV Antibody Tests. Weekly Epidemiol Rec., 20: 145-149.